Company Overview

GINKGO BIOWORKS HOLDINGS, INC.

DNA
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
170M
2025 FY
Net Income
-313M
2025 FY
Shares Outstanding
55M
2025 FY
EPS
-5.64USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1830214
Exchange
NYSE
Location
US